Page last updated: 2024-08-23

fenticonazole and palbociclib

fenticonazole has been researched along with palbociclib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Acconcia, F; Bartoloni, S; Busonero, C; Cipolletti, M; Leone, S; Parente, M	1

Other Studies

1 other study(ies) available for fenticonazole and palbociclib

Article	Year
A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6 Topics: Aminopyridines; Antifungal Agents; Antineoplastic Agents; Benzimidazoles; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clotrimazole; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Approval; Drug Discovery; Drug Repositioning; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; MCF-7 Cells; Piperazines; Proteolysis; Pyridines; Signal Transduction; Spheroids, Cellular	2021

Article

Year

A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells.

International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6

Topics: Aminopyridines; Antifungal Agents; Antineoplastic Agents; Benzimidazoles; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clotrimazole; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Approval; Drug Discovery; Drug Repositioning; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; MCF-7 Cells; Piperazines; Proteolysis; Pyridines; Signal Transduction; Spheroids, Cellular

2021